Binding of peptides in solution by the Escherichia coli chaperone PapD as revealed using an inhibition ELISA and NMR spectroscopy

https://doi.org/10.1016/S0968-0896(98)00162-XGet rights and content

Abstract

PapD is the prototype member of a family of periplasmic chaperones which are required for assembly of virulence associated pili in pathogenic, gram-negative bacteria. In the present investigation, an ELISA has been developed for evaluation of compounds as inhibitors of PapD. Synthetic peptides, including an octamer, derived from the C-terminus of the pilus adhesin PapG were able to inhibit PapD in the ELISA. Evaluation of a panel of octapeptides in the ELISA, in combination with NMR studies, showed that the peptides were bound as extended β-strands by PapD in aqueous solution. The PapD–peptide complex was stabilized by backbone to backbone hydrogen bonds and interactions involving three hydrophobic peptide side chains. This structural information, together with previous crystal structure data, provides a starting point in efforts to design and synthesize compounds which bind to chaperones and interfere with pilus assembly in pathogenic bacteria.

Introduction

Many gram-negative bacteria assemble extracellular adhesive organelles termed pili on their surfaces that allow them to colonize host tissue and give rise to infections.[1] This group of bacteria includes pathogens that cause a variety of diseases, such as urinary tract infection and the more severe pyelonephritis, meningitis, whooping cough, pneumonia and diarrhoea.[2] Pili are rodlike, supramolecular protein fibers that present adhesins at their tip for specific attachment to receptors found in the host.3, 4 The P pilus of uropathogenic Escherichia coli is the best characterized of all bacterial pili and carries the adhesin PapG at the end of a thin tip fibrillum joined to a thicker pilus rod.[1] The mode of binding of the PapG adhesin to the receptor-active disaccharide, α-d-galactopyranosyl-(1-4)-β-d-galactopyranose [Galα(1-4)Galβ], present in the globoseries of glycolipids on kidney epithelium cells,5, 6 has been revealed in detail using synthetic receptor analogues.7, 8, 9 The P pilus tip fibrillar structure is composed of repeating PapE subunits whereas the pilus rod consists of large numbers of the major pilin subunit PapA. The adaptor proteins PapF, PapK, and PapH join the different parts of the pilus to each other and anchor the pilus in the outer cell membrane of the bacteria. All bacterial pilus assembly requires the presence of periplasmic chaperones. P pili are assembled by the chaperone PapD that binds to and caps interactive surfaces on each pilus subunit thus preventing premature aggregation during their secretion into the periplasmic space.10, 11, 12 The crystal structure of PapD has been solved at 2.5 Å resolution and reveals that PapD consists of two β-barrel domains oriented in the shape of a boomerang.[13] Furthermore, PapD has been found to have significant sequence homology (25–56% identity) with chaperones that assemble other types of pili suggesting that all chaperones have closely related structures.2, 14

The C-terminus of the P pilus proteins has been indicated to constitute an essential part of the epitope on each subunit that is recognized by the PapD chaperone.10, 12, 15, 16 Thus, truncation of the C-terminal 13 residues in the adhesin PapG abolished complex formation with PapD.[10] Moreover, synthetic 19-mer peptides from the C-terminus of P-pilus proteins bound to PapD and some of these peptides also inhibited chaperone mediated folding of the adhesin PapG in an in vitro assay.[15] The crystal structure of PapD bound to the C-terminal 19-mer peptide from PapG (PapG296-314), determined at 3.0 Å resolution, suggested a structural basis for chaperone-subunit interactions.[15] It was found that the peptide was anchored by hydrogen and ionic bonding of the C-terminal carboxylate group to residues Arg[8] and Lys112, which are found in the cleft of PapD and are invariant in the chaperone superfamily. Seven main-chain hydrogen bonds were also formed between the peptide backbone and the G1 β-strand on the surface of PapD resulting in a parallel β-strand interaction. Furthermore, the hydrophobic side chains of Phe313, Leu311, Met309, and Met307 in the peptide made significant contact with PapD. Interestingly, these hydrophobic residues are part of a conserved pattern of alternating hydrophobic and hydrophilic residues present in the C-terminus of pilus proteins.[15] However, within the crystal, the PapD-peptide β-sheet was extended even further, since a second PapD-peptide complex was placed adjacent to the first, so that the two bound peptide chains interacted as antiparallel β-strands. It can not be ruled out that the structure of the complex was significantly influenced by this dimerization.

In addition to providing information on how chaperones recognize pilus proteins, studies of the interactions between synthetic peptides and chaperones provide structural information that may be used for design and synthesis of ligands that bind to chaperones. By inhibiting pilus assembly, such compounds would interfere with bacterial attachment to the host; therefore, they constitute potential novel antibiotics. It was recently pointed out that the development of compounds that interfere with bacterial protein secretion (for instance, in pilus assembly) constitutes an attractive approach to overcome widespread bacterial resistance to existing antibiotics.[17] However, such efforts have been hampered by the lack of bioassays, which properly evaluate compounds as inhibitors of the critical complex formation between chaperone and pilus protein.[15] Therefore, we have developed an enzyme-linked immunosorbent assay (ELISA) in which compounds may be evaluated for their ability to inhibit complex formation between PapD and a fusion protein (MaltBP–PapG175-314)[16] which consists of the chaperone binding domain of the PapG linked to the maltose binding protein. Evaluation of a panel of synthetic peptides derived from the C-terminus of P pilus proteins in the assay resulted in the identification of a minimal inhibitory octapeptide. Investigation of alanine and serine scans of this octapeptide in the ELISA, in combination with NMR studies of two peptide–PapD complexes, revealed structural details responsible for the formation of complexes between PapD and peptides in aqueous solution.

Section snippets

Synthesis of pilus-related peptides and a reduced analogue

To enable the present investigation, a number of peptides derived from the C-terminus of the proteins which make up the P pilus have been prepared (peptides are denoted by their pilus protein origin and the fragment they represent within this protein; sequences are shown in Table 1). These synthetic peptides include the five 19-mer peptides (PapG296-314, PapF130-148, PapE131-149, PapK139-157, and PapH155-173)[18] as well as the length series from PapG (ranging in length from C-terminal 19- to

Discussion

Periplasmic chaperones are required for assembly of pili which mediate binding to host tissue in a large number of pathogenic, gram-negative bacteria.[1] Since interference with pilus assembly reduces bacterial virulence, compounds that inhibit chaperone function may constitute novel antibiotics. Chaperones involved in pilus assembly show significant homology to PapD,2, 14 which mediates pilus assembly in uropathogenic E. coli. This suggests that all periplasmic chaperones have structures

Conclusions

Bacterial periplasmic chaperones, such as PapD in E. coli, bind the protein subunits that make up adhesive pili and incorporate them into the functional pilus. An ELISA has now been developed which allows evaluation of compounds as inhibitors of complex formation between PapD and the pilus adhesin PapG. Evaluation of peptides from the C-terminus of the six proteins that make up the E. coli P pilus, revealed that peptides from the adhesin PapG were the most potent PapD inhibitors and that most

Experimental

Abbreviations used: Boc: tert-butoxycarbonyl; CHAPS: 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; COSY: correlated spectroscopy; DIPSI: decoupling in the presence of scalar interactions; ELISA: enzyme linked immunosorbent assay; HATU: O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; HETCOR: heteronuclear correlation spectroscopy; HMQC: heteronuclear multiple quantum coherence spectroscopy; HOAt: 1-hydroxy-7-azabenzotriazole; HSQC: heteronuclear single

Supplementary material

400 MHz 1H NMR spectra and 100 MHz 13C NMR spectra for compounds 3–5. Tabulated 500 MHz 1H NMR data for the peptides PapG296-314, PapE131-149, PapK139-157, and PapH155-173.

Acknowledgements

The authors are grateful to C. Pongratz for statistical analysis of the ELISA data for the pilus subunit derived 19-mer peptides, S. Linse for the gift of Calbindin D28k, G. Carlström for pulse sequence programming (TRNOE) and G. Carlström and J. Evenäs for help with the 3-D-NOESY-HSQC NMR experiments. This work was funded by the Swedish National Board for Industrial and Technical Development and by the Swedish Natural Science Research Council.

References (63)

  • Hultgren, S. J.; Abraham, S.; Caparon, M.; Falk, P.; St. Geme, J. W., III; Normark, S. Cell 1993, 73,...
  • Hung, D. L.; Knight, S. D.; Woods, R. M.; Pinkner, J. S.; Hultgren, S. J. EMBO J. 1996, 15,...
  • Kuehn, M. J.; Heuser, J.; Normark, S.; Hultgren, S. J. Nature 1992, 356,...
  • Bullitt, E.; Makowski, L. Nature 1995, 373,...
  • Källenius, G.; Möllby, R.; Svenson, S. B.; Winberg, J.; Lundblad, A.; Svensson, S.; Cedergren, B. FEMS Lett. 1980, 7,...
  • Leffler, H.; Svanborg Edén, C. FEMS Lett. 1980, 8,...
  • Kihlberg, J.; Hultgren, S. J.; Normark, S.; Magnusson, G. J. Am. Chem. Soc. 1989, 111,...
  • Striker, R.; Nilsson, U.; Stonecipher, A.; Magnusson, G.; Hultgren, S. J. Mol. Microbiol. 1995, 16,...
  • Nilsson, U.; Striker, R. T.; Hultgren, S. J.; Magnusson, G. Bioorg. Med. Chem. 1996, 4,...
  • Hultgren, S. J.; Lindberg, F.; Magnusson, G.; Kihlberg, J.; Tennent, J. M.; Normark, S. Proc. Natl. Acad. Sci. U.S.A....
  • Kuehn, M. J.; Normark, S.; Hultgren, S. J. Proc. Natl. Acad. Sci. U.S.A. 1991, 88,...
  • Bullitt, E.; Jones, C. H.; Striker, R.; Soto, G.; Jacob-Dubuisson, F.; Pinkner, J.; Wick, M. J.; Makowski, L.;...
  • Holmgren, A.; Brändén, C.-I. Nature 1989, 342,...
  • Holmgren, A.; Kuehn, M. J.; Brändén, C.-I.; Hultgren, S. J. EMBO J. 1992, 11,...
  • Kuehn, M. J.; Ogg, D. J.; Kihlberg, J.; Slonim, L. N.; Flemmer, K.; Bergfors, T.; Hultgren, S. J. Science 1993, 262,...
  • Xu, Z.; Jones, C. H.; Haslam, D.; Pinkner, J. S.; Dodson, K.; Kihlberg, J.; Hultgren, S. J. Mol. Microbiol. 1995, 16,...
  • Stephens, C.; Shapiro, L. Chem. Biol. 1997, 4,...
  • Flemmer Karlsson, K.; Walse, B.; Drakenberg, T.; Kihlberg, J. Lett. Peptide Sci. 1996, 3,...
  • Cameron, L. R.; Holder, J. L.; Meldal, M.; Sheppard, R. C. J. Chem. Soc. Perkin Trans. 1. 1988,...
  • Garegg, P. J.; Samuelsson, B. J. Chem. Soc. Perkin Trans. 1. 1980,...
  • Carpino, L. A.; El-Faham, A.; Minor, C. A.; Albericio, F. J. Chem. Soc., Chem. Commun. 1994,...
  • Carpino, L. A. J. Am. Chem. Soc. 1993, 115,...
  • Carpino, L. A.; El-Faham, A. J. Org. Chem. 1994, 59,...
  • Flemmer, K.; Xu, Z.; Pinkner, J. S.; Hultgren, S. J.; Kihlberg, J. Bioorg. Med. Chem. Lett. 1995, 5,...
  • Derrick, J. P.; Wigley, D. B. Nature 1992, 359,...
  • Wüthrich, K. NMR of Proteins and Nucleic Acids; New York: Wiley & Sons,...
  • Dyson, H. J.; Wright, P. E. Annu. Rev. Biophys. Biophys. Chem. 1991, 20,...
  • Bundi, A.; Grathwohl, C.; Hochmann, J.; Keller, R. M.; Wagner, G.; Wüthrich, K. J. Magn. Reson. 1975, 18,...
  • Wishart, D. S.; Bigham, C. G.; Holm, A.; Hodges, R. S.; Sykes, B. D. J. Biomol. NMR. 1995, 5,...
  • Gronenborn, A. M.; Clore, G. M. Crit. Rev. Biochem. Mol. Biol. 1995, 30,...
  • Ni, F. Prog. Nucl. Magn. Reson. Spectrosc. 1994, 26,...
  • Cited by (11)

    View all citing articles on Scopus
    View full text